Biovica International Investor Relations Material
Latest events
Q3 2025
Biovica International
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biovica International
Access all reports
Biovica International AB, a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. The company's focus is on prediction of treatment efficacy and prognosis, thereby providing physicians with objective decision-making tools that enable informed treatment choice. The company is based in Uppsala, Sweden.
Key slides for Biovica International
Q1 2025
Biovica International
Q1 2025
Biovica International
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
BIOVIC
Country
🇸🇪 Sweden